Salvatore Alesci
Corporate Officer/Principal at TAKEDA PHARMACEUTICAL COMPANY LIMITED
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christophe Weber | M | 57 | 10 years | |
Krishnan Nandabalan | M | 61 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Masami Iijima | M | 73 | 3 years | |
Constantine Saroukos | M | 53 | 9 years | |
Andrew Plump | M | 58 | 9 years | |
Yoshiaki Fujimori | M | 71 | 8 years | |
Patricia Spera | M | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Miki Tsusaka | F | 61 | 1 years | |
Jason Fenton | M | 48 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 years |
Kimberly Reed | F | 53 | 2 years | |
Takashi Okubo | M | - | - | |
Jean-Luc Butel | M | 67 | 8 years | |
Norimasa Takeda | M | - | - | |
Jonathan Zalevsky | M | 49 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Michel Orsinger | M | 66 | 8 years | |
Kerrie L. Brady | F | 62 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Demetrios Kydonieus | M | 54 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Ian Clark | M | 62 | 5 years | |
Koji Hatsukawa | M | 72 | 8 years | |
Emiko Higashi | F | 64 | 8 years | |
Haruhiko Hirate | M | - | - | |
Olivier Jean Bohuon | M | 65 | 5 years | |
Steven Gillis | M | 71 | 5 years | |
John Maraganore | M | 60 | 2 years | |
Jun Ueki | M | - | 5 years | |
Michael Mendelsohn | M | 69 | 9 years | |
Gabriele Ricci | M | 45 | 2 years | |
Ramy Riad | M | - | 5 years | |
Lauren Duprey | F | 40 | - | |
Shunichiro Okada | M | 66 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 years |
Aman Kant | M | 40 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Sheryl Bauer | F | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 2 years |
Elizabeth Borgeson | F | - | - | |
Julie So-Young Kim | F | - | - | |
Christopher O'Reilly | M | - | 13 years | |
Marcello Agosti | M | 53 | 5 years | |
Ricardo Marek | M | - | - | |
Chris Slavinsky | M | 52 | - | |
Satoru Takemoto | M | - | - | |
Michael Aiello | M | 44 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Teresa Bitetti | F | - | - | |
Rupa Cornell | M | - | - | |
Yoshihiro Nakagawa | M | 45 | - | |
Mwana Lugogo | M | 54 | 12 years | |
Giles Platford | M | - | 7 years | |
Anita Ganjoo | M | - |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sandeep Laumas | M | 56 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | - |
Vimal Mehta | M | 63 |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Japan | 35 | 72.92% |
United States | 13 | 27.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Salvatore Alesci
- Personal Network